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Abstract
Background: Secretory carcinoma of the male breast (juvenile carcinoma) is a rare neoplasm.
Only a few cases have been reported in the literature.
Case report: We report here a case in a 17-year old male presenting with recurrent breast
swelling.
Conclusions: Though considered an indolent neoplasm, secretory carcinoma does metastasise to
lymph nodes and recur after local excision. Surgery in form of mastectomy with axillary clearance
is the treatment of choice.
Introduction
Male breast carcinoma is a relatively rare neoplasm
accounting for less than 1% of all breast cancers [1]. It is a
disease of the elderly, with a peak incidence around 60
years of age [2]. Majority of the cases are infiltrating duct
carcinomas (70%–95%) [2]. It is extremely rare in boys
and young adults. At our centre, 5 cases of carcinoma of
the male breast were treated out of a total of 594 breast
cancers, during the period 1997 – 2002. One of these was
a rare form of breast carcinoma in a 17-year-old boy,
which forms the basis of this report.
Secretory carcinoma is a rare variant of breast carcinoma
with a relatively good prognosis. Most of the patients are
females and it is very rare in males [4]. A review of litera-
ture revealed only 15 cases of secretory breast carcinoma
in males and this is the first reported case from India [3-
18].
Case presentation
A 17-Year-old male presented with a swelling over the
right breast. He had underwent excision of a lump at a
peripheral hospital two years ago for a swelling in the sub-
areolar region of the right breast with a fine needle aspira-
tion cytology (FNAC) report of benign epithelial
proliferative lesion. Histopathological report of the
lumpectomy specimen was invasive lobular carcinoma
following which he was referred to an oncologist and
mastectomy was advised. Instead, he took herbal medi-
cines. He developed recurrence on the same site within six
months. He reported to the oncologist and chemotherapy
using cyclophosphamide, methotrexate and 5 fluorour-
acil (CMF-regimen) was initiated. He was irregular and
discontinued the treatment in between.
On examination there was a 5 × 4-cm tumour in the sub
areolar region with skin infiltration and multiple satellite
nodules around the main lesion (figure 1) and multiple
mobile ipsilateral axillary lymph nodes. There was no
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evidence of distant spread. A modified radical mastec-
tomy was performed. Postoperative period was
uneventful.
Examination of the mastectomy specimen showed a cir-
cumscribed neoplasm measuring 6 × 3.5 cm, involving
the overlying nipple. Cut section of the growth showed
whitish appearance. The axillary pad of fat showed twelve
lymph nodes largest measuring 2 cm. Cut section of most
of the lymph nodes showed whitish appearance.
Microscopic examination showed a neoplasm composed
of cells arranged in glandular patterns with eosinophilic
secretion within the lumen (figure 2). The tumour cells
showed intra cytoplasmic lumen-formation with secre-
tion (figure 3). The secretion was Periodic acid- Schiff
(PAS) positive and diastase resistant material (figure 4).
The cells showed only mild nuclear pleomorphism and
no mitotic activity; however areas of necrosis were seen.
The neoplasm was seen invading the overlying nipple and
the posterior resected margin was free. A diagnosis of
secretory carcinoma of the breast was made.
Of the twelve axillary lymph nodes dissected, ten showed
metastatic deposits. The tumour was oestrogen receptor
negative and the progesterone receptor status was not
studied. As the specimen blocks of first surgery could not
Clinical photograph showing the breast mass with involvement of the skin Figure 1
Clinical photograph showing the breast mass with involvement of the skin.World Journal of Surgical Oncology 2004, 2 http://www.wjso.com/content/2/1/17
Page 3 of 6
(page number not for citation purposes)
be retrieved no comments regarding the status of margins
of first surgery could be made.
He received postoperative radiotherapy and was started
on 10 mg twice daily tamoxifen. He is asymptomatic with
no evidence of recurrence or metastasis 13 months after
mastectomy.
Discussion
Secretory carcinoma of the breast is a rare entity, most
commonly seen in females and its occurrence in male is
even rarer with only 15 cases reported in the world litera-
ture [3-18]. Secretory carcinoma though known previ-
ously as juvenile breast carcinoma [19] has been reported
in all age groups. In the mix series of Tavassoli and Norris
the median age at diagnosis was 25 years [4]. In the recent
review of data of 15 male patients by de Bree et al, the
median age was 17 years [18]. Secretory carcinoma seems
to occur at a younger age in males than females [18].
Characteristically the tumour presents as a circumscribed
and mobile mass in the subareolar location. Most charac-
teristic histological feature is the presence of abundant
intra and extra cellular secretory material and tumour cells
with vacuolated or granular eosinophilic cytoplasm [4].
Intracytoplasmic lumen is seen frequently (figure 3). The
secretory material is PAS positive and diastase resistant.
Fine needle aspiration cytology (FNAC) shows presence of
prominent intracytoplasmic vacuolisation [9]. Vesoulis
and Kashkari reported that cytological features of secre-
tory breast carcinoma resemble that of benign epithelial
Photomicrograph showing cells arranged in glandular pattern with eosinophilic secretion within lumen (Haematoxylin and  Eosin × 100) Figure 2
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proliferative lesions; particularly lactational changes or
lactating adenoma [11] and this could be the reason for
missing the diagnosis on FNAC in the present case.
The prognosis for secretory carcinoma is favourable when
compared with ductal carcinoma. Tavassoli and Norris
suggested three features of secretory carcinoma that indi-
cate a favourable prognosis: (1) tumour size less than 2
cm, (2) age of less than 20 years at diagnosis and (3)
tumour with circumscribed margins [4].
Case reports of local recurrence following local excision
suggest that local excision alone may not be adequate and
many have advocated mastectomy [4,5,7,19]. Lymph
node metastasis is observed in approximately 20–30% of
the recorded cases [4,20]. It is rare in females with tumour
<2 cm [4]. It has been suggested by de Bree et al, that in
males nodal metastasis might occur more frequently in
smaller tumours [18]. Therefore mastectomy with axillary
lymph node dissection or sentinel lymph node biopsy is
recommended in males [18].
Distant metastases from secretory carcinoma are
extremely rare with only four cases reported [7,21]. Metas-
tasis has been reported even after 20 years of surgery. In
males, recurrence has been reported in only one case [18].
Herz et al, has reported non-responsiveness of the tumour
to chemotherapy [21]. Even though adjuvant therapy has
been administered in many cases there is no evidence to
support any form of therapy [18]. In our case, tumour size
of 6 cm and presence of metastasis in 10 axillary nodes
suggests a relatively poor prognosis. However secretory
Tumour cells showing intracytoplasmic lumen formation with secretion (Haematoxylin and Eosin × 400) Figure 3
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carcinoma being an indolent tumour, a long-term follow-
up is required to derive definite conclusions.
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